Abbott received European CE Mark of approval for its TactiCath Contact Force Ablation Catheter, Sensor Enabled for treatment of atrial fibrillation. The device features a pressure sensor that provides feedback on the contact force applied to cardiac tissue, helping to make sure that an appropriate amount of ablation takes place. Coupled with the company’s EnSite Precision cardiac mapping system, the tip of the catheter can be guided to target lesions while having a live map of the relevant anatomy, including its electrical activity, and the catheter’s location within it.
The TactiCath has a magnetic sensor that lets EnSite Precision spot its location within the heart, while when ablation is proceeding the catheter is constantly monitored to make sure its stable and delivering energy while in proper contact with the heart. The catheter is promised to be easy to steer through difficult anatomy, in part thanks to a 1:1 transfer of torque from the handle to the tip of the device.
From Abbott:
The clinical evidence show use of optimal Contact Force guided AF ablation with the TactiCath™ Quartz catheter resulted in clinical success in 85.5% of patients and fewer post-ablation clinical events, translating to a 15% reduction in post-ablation management costs ($3,402 savings per patient) in the year after ablation vs. patients treated with a non-contact force ablation catheter.
Flashbacks: TactiCath Quartz Contact Force Ablation Catheter…; Endosense’s TactiCath Quartz Force Sensing Cardiac Ablation Cath Now Available in Europe…; TactiCath Pressure Sensing Ablation Catheter Soon Available in Europe…
Product page: TactiCath…
Via: Abbott…